Citation

Kausch O. J. Neuropsychiatry Clin. Neurosci. 2014; 26(2): 172-175.

Copyright

(Copyright © 2014, American Neuropsychiatric Association, Publisher American Psychiatric Publishing)

DOI

10.1176/appi.neuropsych.13030045

PMID

unavailable

Abstract

The U.S. Food and Drug Administration has warned that patients being treated for smoking cessation with varenicline may develop depression. A case of successful treatment for depression with varenicline is described. The patient's depression recurred several times with inadvertent varenicline discontinuation, then remitted again after resuming varenicline. The literature supporting the potential use of varenicline for depression is reviewed. © 2014 by the American Psychiatric Association.

Language: en

Keywords

Humans; Male; Middle Aged; adult; human; Depression; male; case report; depression; suicide attempt; major depression; psychology; Smoking; article; smoking; sertraline; priority journal; paranoia; middle aged; drug withdrawal; bipolar II disorder; anhedonia; smoking cessation; varenicline; Nicotinic Agonists; benzazepine derivative; Benzazepines; nicotinic agent; quinoxaline derivative; Quinoxalines